Long-term Protection Against Herpes Zoster by the Adjuvanted Recombinant Zoster Vaccine: Interim Efficacy, Immunogenicity, and Safety Results up to 10 Years After Initial Vaccination
Open Forum Infectious Diseases, Volume 9, No. 10, Article ofac485, Year 2022